News
Hosted on MSN1mon
HLA-DRB1 molecule offers potential target for CAR therapy in relapsed acute myeloid leukemia post-transplantationThe KG2032 CAR T cells displayed strong and specific anti-AML effects in vitro with cell culture experiments, as well as in vivo with a mouse model. The treated mice did not display any overt ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback